Cancer Drug Raises Risk of Cardiovascular Toxicity

| January 1, 2018

article image
A drug approved by the FDA in 2012 to treat a type of cancer called multiple myeloma has dangerous side effects that involve the heart. The drug is called carfilzomib, and it is a proteasome inhibitor now linked to an increased risk of dangerous heart events. High blood pressure, heart failure, heart attack, stroke, and arrhythmias are all examples of adverse cardiac events (ACEs), which, from a new Abramson Cancer Center study at the University of Pennsylvania, are now associated with multiple myeloma (MM) patients prescribed carfilzomib.

Spotlight

Lucas Medical Inc.

Lucas Medical, Inc. is a California based medical device manufacturing organization, was established to develop, manufacture and market superior alternatives to existing vascular products. The Company was incorporated in the State of California in September 1994. Innovation, R&D and customer demand for cutting edge products and services drives our success.We do business globally with sales and distribution presence in U.S.A, Germany, Italy, Spain, Sweden, Turkey , Mexico, Chile, Brazil, Israel, Japan, India and Sri Lanka.

OTHER ARTICLES

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 9, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Spotlight

Lucas Medical Inc.

Lucas Medical, Inc. is a California based medical device manufacturing organization, was established to develop, manufacture and market superior alternatives to existing vascular products. The Company was incorporated in the State of California in September 1994. Innovation, R&D and customer demand for cutting edge products and services drives our success.We do business globally with sales and distribution presence in U.S.A, Germany, Italy, Spain, Sweden, Turkey , Mexico, Chile, Brazil, Israel, Japan, India and Sri Lanka.

Events